Follow
Dr. Pere Fontova Palé
Dr. Pere Fontova Palé
PostDoc Researcher, Universitat de Barcelona
Verified email at ub.edu
Title
Cited by
Cited by
Year
TGF‐β1 targets Smad, p38 MAPK, and PI 3K/Akt signaling pathways to induce PFKFB 3 gene expression and glycolysis in glioblastoma cells
A Rodríguez‐García, P Samsó, P Fontova, H Simon‐Molas, A Manzano, ...
The FEBS Journal 284 (20), 3437-3454, 2017
1392017
Online haemodiafiltration improves inflammatory state in dialysis patients: a longitudinal study
I Rama, I Llaudo, P Fontova, G Cerezo, C Soto, C Javierre, M Hueso, ...
PLoS One 11 (10), e0164969, 2016
262016
PI3K–Akt signaling controls PFKFB3 expression during human T-lymphocyte activation
H Simon-Molas, C Arnedo-Pac, P Fontova, A Vidal-Alabro, E Castaño, ...
Molecular and Cellular Biochemistry 448, 187-197, 2018
252018
Evaluation of linezolid or trimethoprim/sulfamethoxazole in combination with rifampicin as alternative oral treatments based on an in vitro pharmacodynamic model of …
C El Haj, O Murillo, A Ribera, N Lloberas, J Gómez-Junyent, F Tubau, ...
International journal of antimicrobial agents 51 (6), 854-861, 2018
242018
Donor/recipient HLA molecular mismatch scores predict primary humoral and cellular alloimmunity in kidney transplantation
M Meneghini, E Crespo, M Niemann, A Torija, N Lloberas, V Pernin, ...
Frontiers in immunology 11, 623276, 2021
202021
Influence of the circadian timing system on tacrolimus pharmacokinetics and pharmacodynamics after kidney transplantation
P Fontova, H Colom, R Rigo-Bonnin, LN Van Merendonk, A Vidal-Alabro, ...
Frontiers in Pharmacology 12, 636048, 2021
182021
The gene silencing of IRF5 and BLYSS effectively modulates the outcome of experimental lupus nephritis
J Guiteras, É Ripoll, N Bolaños, L De Ramon, P Fontova, N Lloberas, ...
Molecular Therapy-Nucleic Acids 24, 807-821, 2021
92021
TGF-b1 targets Smad, p38 MAPK, and PI3K/Akt signaling pathways to induce PFKFB3 gene expression and glycolysis in glioblastoma cells
A Rodrıguez-Garcıa, P Samsó, P Fontova, H Simon-Molas, A Manzano, ...
FEBS J 284 (20), 3437-54, 2017
92017
Sustained Inhibition of Calcineurin Activity With a Melt‐Dose Once‐daily Tacrolimus Formulation in Renal Transplant Recipients
P Fontova, H Colom, R Rigo‐Bonnin, O Bestard, A Vidal‐Alabró, ...
Clinical Pharmacology & Therapeutics 110 (1), 238-247, 2021
82021
Measurement of calcineurin activity in peripheral blood mononuclear cells by ultra-high performance liquid chromatography-tandem mass spectrometry. Renal transplant recipients …
P Fontova, R Rigo-Bonnin, A Vidal-Alabro, G Cerezo, O Bestard, ...
Clinica Chimica Acta 495, 287-293, 2019
72019
ANRIL as a genetic marker for cardiovascular events in renal transplant patients – an observational follow‐up cohort study
A Arbiol‐Roca, A Padró‐Miquel, A Vidal‐Alabró, M Hueso, P Fontova, ...
Transplant International 31 (9), 1018-1027, 2018
62018
Dual and opposite costimulatory targeting with a novel human fusion recombinant protein effectively prevents renal warm ischemia reperfusion injury and allograft rejection in …
J Guiteras, L De Ramon, E Crespo, N Bolaños, S Barcelo-Batllori, ...
International Journal of Molecular Sciences 22 (3), 1216, 2021
52021
A novel late-stage autophagy inhibitor that efficiently targets lysosomes inducing potent cytotoxic and sensitizing effects in lung cancer
A Molero-Valenzuela, P Fontova, D Alonso-Carrillo, I Carreira-Barral, ...
Cancers 14 (14), 3387, 2022
42022
TP53-induced glycolysis and apoptosis regulator (TIGAR) is upregulated in lymphocytes stimulated with concanavalin A
H Simon-Molas, X Vallvé-Martínez, I Caldera-Quevedo, P Fontova, ...
International Journal of Molecular Sciences 22 (14), 7436, 2021
42021
Mycophenolic acid interferes the transcriptional regulation and protein trafficking of maturation surface markers in dendritic cells
P Fontova, I Rama, I Llaudó, A Vidal-Alabró, G Cerezo, A Manzano, ...
International Immunopharmacology 91, 107025, 2021
42021
Validation and evaluation of four sample preparation methods for the quantification of intracellular tacrolimus in peripheral blood mononuclear cells by UHPLC-MS/MS
LN van Merendonk, P Fontova, R Rigo-Bonnin, H Colom, A Vidal-Alabró, ...
Clinica Chimica Acta 503, 210-217, 2020
42020
A potent fluorescent transmembrane HCl transporter perturbs cellular pH and promotes cancer cell death
M Fares, X Wu, DA McNaughton, AM Gilchrist, W Lewis, PA Keller, ...
Organic & Biomolecular Chemistry 21 (12), 2509-2515, 2023
32023
Dual costimulatory and coinhibitory targeting with a hybrid fusion protein as an immunomodulatory therapy in lupus nephritis mice models
J Guiteras, E Crespo, P Fontova, N Bolaños, M Gomà, E Castaño, ...
International Journal of Molecular Sciences 23 (15), 8411, 2022
32022
A prospective controlled, randomized clinical trial of kidney transplant recipients developed personalized tacrolimus dosing using model-based Bayesian Prediction
N Lloberas, JM Grinyó, H Colom, A Vidal-Alabró, P Fontova, ...
Kidney International 104 (4), 840-850, 2023
22023
The Effect of Intracellular Tacrolimus Exposure on Calcineurin Inhibition in Immediate-and Extended-Release Tacrolimus Formulations
P Fontova, LN van Merendonk, A Vidal-Alabró, R Rigo-Bonnin, G Cerezo, ...
Pharmaceutics 15 (5), 1481, 2023
22023
The system can't perform the operation now. Try again later.
Articles 1–20